{"filing":{"accession_number":"0001104659-26-118499","cik":"0001756655","ticker":"ARDT","company_name":"Ardent Health, Inc.","form":"8-K","filing_date":"2026-10-23","report_date":"2026-10-19","primary_document":"tm2628189d2_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1756655/000110465926118499/tm2628189d2_8k.htm"},"events":[{"id":37666,"run_id":34712,"accession_number":"0001104659-26-118499","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Martin J. Bonick's departure as President and CEO effective June 2, 2026, is the principal disclosed action, with the October 19, 2026 Board determination recharacterizing his separation as a termination for \"Cause\" due to failure to disclose compensation from third parties. While the filing also addresses severance modifications (cancellation of ~$4.5 million in payments and forfeiture of PRSUs), the core event is the executive's departure and the Board's post-hoc determination of cause, making this fundamentally an exec_departure disclosure rather than a compensation arrangement.","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-10-23","form":"8-K","submitted_at":null,"items":[{"id":42450,"accession_number":"0001104659-26-118499","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Martin J. Bonick's departure as President and CEO effective June 2, 2026, is the principal disclosed action, with the October 19, 2026 Board determination recharacterizing his separation as a termination for \"Cause\" due to failure to disclose compensation from third parties. While the filing also addresses severance modifications (cancellation of ~$4.5 million in payments and forfeiture of PRSUs), the core event is the executive's departure and the Board's post-hoc determination of cause, making this fundamentally an exec_departure disclosure rather than a compensation arrangement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T20:53:57.339003+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42450,"accession_number":"0001104659-26-118499","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Martin J. Bonick's departure as President and CEO effective June 2, 2026, is the principal disclosed action, with the October 19, 2026 Board determination recharacterizing his separation as a termination for \"Cause\" due to failure to disclose compensation from third parties. While the filing also addresses severance modifications (cancellation of ~$4.5 million in payments and forfeiture of PRSUs), the core event is the executive's departure and the Board's post-hoc determination of cause, making this fundamentally an exec_departure disclosure rather than a compensation arrangement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T20:53:57.339003+00:00","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-10-23"}]}